Optos Achieves ISO 27001:2022 Certification and U.S. Department of Defense Authority to Operate

Reinforcing a Global Commitment to Secure, Compliant, and Trusted Ultra-Widefield Imaging Solutions

Dunfermline, Scotland – 19 August 2025 – Optos, a leading provider of ultra-widefield retinal imaging technology, today announced that it has achieved both Stage 2 ISO 27001:2022 certification and Authority to Operate (ATO) from the U.S. Department of Defense (DoD). Together, these milestones reflect Optos’ ongoing commitment to providing secure, reliable, and compliant imaging systems for eyecare professionals around the world.

ISO 27001:2022 is the latest international standard for information security management systems (ISMS). Achieving certification to this updated standard demonstrates Optos’ proactive and comprehensive approach to managing data security across its organization, from device-level protection to cloud-based software platforms. This confirms that Optos adheres to globally recognized best practices for safeguarding sensitive information.

The U.S. Department of Defense ATO was granted following a rigorous evaluation process, including extensive penetration testing and review against stringent cybersecurity requirements. The designation authorizes Optos solutions to be used within military and defense healthcare environments, underscoring their alignment with some of the most demanding information security standards worldwide.

“Security and trust are fundamental to the way we serve our customers,” said Quinn Lyzun, Deputy CEO. “These certifications reflect our continued investment in data protection and give our partners additional confidence in the systems they rely on to deliver high-quality patient care.”

These achievements offer important benefits to eyecare providers:

•    Enhanced Confidence: Optos systems are designed with rigorous cybersecurity controls to protect patient data.

•    Operational Compatibility: The certifications help ensure alignment with clinical and IT infrastructure requirements.

•    Preparedness for the Future: With rising regulatory expectations and increased patient focus on privacy, partnering with certified vendors helps providers remain ahead of evolving demands.

These certifications further build on the Optos track record of innovation and its mission to support clinicians with imaging solutions that advance care without compromising security, compliance, or trust.

For more information about Optos and our industry-leading imaging technology, please visit www.optos.com

About Optos

For more than 30 years, Optos has been the exclusive provider of 200-degree single-shot ultra-widefield retinal imaging systems to eye care professionals worldwide. With over 27,000 devices in use and supported by more than 3,000 clinical papers.

Optos has also developed integrated ultra-widefield retinal imaging with optomap-guided Optical Coherence Tomography (OCT). Optos devices facilitate the early detection, management, and effective treatment of disorders and diseases evidenced in the retina such as retinal detachments and tears, glaucoma, diabetic retinopathy, and age-related macular degeneration. Optos continues to lead the way in retinal imaging technology, setting the standard for excellence and innovation in eye care.

Media Contact

Cassy Dump
Shine Communications for Optos
Cassy@heyshine.com
(619) 971-1887

Organization Contact

Sharon Shepard
sshepard@optos.com

 

# # #